期刊文献+

盐酸缬更昔洛韦的合成工艺改进

Improvement of synthetic technology of valganciclovir hydrochloride
下载PDF
导出
摘要 目的盐酸缬更昔洛韦的合成工艺改进。方法以更昔洛韦为原料,经乙酰基保护单羟基制得O-单乙酰更昔洛韦,与Cbz-L-缬氨酸经缩合,再经盐酸脱乙酰基得更昔洛韦-Cbz-L-单缬氨酸酯,酸化后在连续流反应器中催化氢化脱苄氧羰基得盐酸缬更昔洛韦粗品,粗品在异丙醇/水(2:1,V/V)中重结晶得到盐酸缬更昔洛韦。结果工艺改进后的操作更加简便安全,可以实现长时间稳定和安全的连续流生产及后处理,目标产品1的收率和纯度得到提高,总收率48.8%,纯度99.4%。结论为盐酸缬更昔洛韦的合成提供了一种较新的方法,生产成本得以降低。 Objective To improve the synthesis process of valganciclovir hydrochloride.Methods Valganciclovir hydrochloride was synthesized from ganciclovir by protection with acetyl to give O-monoacylganciclovir,which was subjected to condensation with Cbz-L-valine and deacetylated hydrochloride to obtain ganciclovir-Cbz-L-monovaline ester.After ganciclovir-Cbz-L-monovaline was acidified,hydrogenation of debenzyloxycarbonyl in a continuous flow reactor was catalyzed to obtain valganciclovir hydrochloride crude product,and the crude product was recrystallized in isopropanol/water(2:1)to obtain valganciclovir hydrochloride.Result The improved process made the operation more convenient and safe,enabling long-term stable and safe continuous production and post-treatment.The yield and purity of target product 1 had been improved,with a total yield of 48.8%and a purity of 99.4%.Conclusion This research provided a relatively new method for the synthesis of valganciclovir hydrochloride,reducing production costs.
作者 薛娜 马彦 张玉辉 张恺 陈兴贺 Xue Na;Ma Yan;Zhang Yuhui;Zhang Kai;Chen Xinghe(Hebei Chemical and Pharmaceutical College,Shijiazhuang 050026;Department of Medicinal Chemistry,Hebei Medical University,Shijiazhuang 050017;Renhe Yikang group New Drug Research and Development Hebei Co.,Ltd.,Shijiazhuang 050035)
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2024年第7期804-808,共5页 Chinese Journal of Antibiotics
基金 河北省教育厅科学研究项目资助(No.ZD2021313) 河北省科技重大专项项目(No.22282603Z) 河北省自然科学基金资助项目(No.H2021418001)。
关键词 盐酸缬更昔洛韦 抗病毒药 合成 工艺改进 连续流 Valganciclovir hydrochloride Antiviral Synthesis Improved synthesis Continuous flow
  • 相关文献

参考文献4

二级参考文献42

  • 1齐隽,郭义峰,闵志廉.更昔洛韦预防肾移植术后巨细胞病毒感染[J].中国新药与临床杂志,2005,24(1):47-49. 被引量:6
  • 2黄樱,王红.肾移植术后巨细胞病毒感染的防治[J].中华器官移植杂志,2005,26(4):252-253. 被引量:7
  • 3李艳萍,李卓荣,山广志.抗病毒药物缬更昔洛韦的合成研究[J].中国抗生素杂志,2005,30(6):336-337. 被引量:6
  • 4张明,钟建泳,瞿连喜,陆福明.更昔洛韦预防肾移植术后巨细胞病毒感染的前瞻性随机对照研究[J].中华器官移植杂志,2006,27(8):452-455. 被引量:10
  • 5Sagedal S, Hartmarm A, Nordal KP, et al. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival[J].Kidney Int, 2004,66 ( 1 ):329 - 337.
  • 6Murray BM, Subramaniam S. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients [-J]. Transpl Infect Dis ,2004,6:3 - 9.
  • 7Sagedal S, Nordal XP, Hartmann A. Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study [ J ]. Nephrol Dial Transplant, 2003,18 : 1 899 - 1 908.
  • 8Pascual J, Alarcon MC, Marcen R, et al. Cytomegalovirus infection after renal transplantation: selective prophylaxis and treatment[J]. Transplant Proc ,2003,35 : 1 756 - 1 757.
  • 9Reisehig T, Opatrny Jr. K, Treska V, et al. Prospective comparison of valaeyclovir and oral ganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipients[J].Kidney Blood Pressure Res ,2005,4:218 - 225.
  • 10Rondeau E, Bourgeon B, Peraldi MN, et al. Effect of prophylactic ganciclovir on cytomegalovirus infection in renal transplant recipients[J]. Nephrol Dial Transplantation , 1993,8 : 858 - 862.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部